Physician profile
Eileen Chen
NPI 1831621937
$505.39
in general payments reported to CMS, 2019-2025
11 companies · $228 in 2025
The $228 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $32.28 · 2024: $245 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $84.99 | 2024 | |
| Acrotech Biopharma INC. | $84.91 | 2024-2025 | Beleodaq |
| Astellas Pharma US INC | $70.13 | 2024-2025 | Vyloy, Xospata |
| Medtronic, INC. | $64.33 | 2024-2025 | Corevalve Evolut R |
| Glaxosmithkline, LLC. | $46.48 | 2024 | Ojjaara |
| Sobi, INC | $32.28 | 2023 | |
| Abiomed | $31.73 | 2025 | |
| Cordis US Corp. | $29.42 | 2025 | Mynx Control Venous |
| Abbott Laboratories | $23.72 | 2025 | Triclip |
| Springworks Therapeutics, INC. | $23.22 | 2025 | Ogsiveo |
| Chiesi USA, INC. | $14.18 | 2024 | Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eileen Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.